Pharmaceutical Profiles

Pharmaceutical Profiles, now part of Quotient Sciences, was a specialist contract research organization (CRO) focused on early-phase drug development and clinical pharmacology. The company was a pioneer in using gamma scintigraphy to visualize drug delivery and transit within the human body, providing critical data on formulation performance. Its proprietary RapidFACT (Rapid Formulation development and Clinical Testing) platform revolutionized the industry by integrating formulation development, real-time manufacturing, and clinical testing. This approach significantly accelerated the transition from lead candidate to proof-of-concept by allowing for data-driven adjustments to drug products during clinical trials. Today, its legacy continues as the core of Quotient Sciences' integrated drug development services.